Janet Woodcock, acting FDA commissioner (Michael Brochstein/Sipa USA/Sipa via AP Images)
House Oversight Committee digs in on McKinsey's conflicting ties with FDA, opioids, and blocking Humira competitors
McKinsey is under fire again, this time from the House Oversight Committee, which is digging into the consulting firm’s close ties to the FDA while …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
